Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
Sales | 568 | 1 | 2 | 0 | 37 |
Gross Profit | 551 | 1 | 2 | N/A | 37 |
Operating Expenses | 29,451 | 22,523 | 20,291 | 16,232 | 15,330 |
Operating Income | -28,883 | -22,522 | -20,289 | -16,232 | -15,293 |
Interest Expense | 2,239 | 1,677 | 729 | 0 | 0 |
Other Income | 86 | 839 | 222 | 204 | 218 |
Pre-tax Income | -31,036 | -23,360 | -20,796 | -16,028 | -15,075 |
Income Tax | -1,679 | N/A | -51 | N/A | N/A |
Net Income Continuous | -29,357 | -23,360 | -20,745 | -16,028 | -14,960 |
Net Income | $-29,357 | $-23,360 | $-20,745 | $-16,028 | $-14,960 |
EPS Basic Total Ops | -1.28 | -1.04 | -0.93 | -0.72 | -0.68 |
EPS Basic Continuous Ops | -1.28 | -1.04 | -0.93 | -0.72 | -0.68 |
EPS Diluted Total Ops | -1.28 | -1.04 | -0.93 | -0.72 | -0.68 |
EPS Diluted Continuous Ops | -1.28 | -1.04 | -0.93 | -0.72 | -0.68 |
EBITDA(a) | $-28,333 | $-21,923 | $-20,295 | $-15,725 | $-15,016 |